TH17-suppressing Pregnancy Proteins May Be MS Therapeutic Target

TH17-suppressing Pregnancy Proteins May Be MS Therapeutic Target

286420

TH17-suppressing Pregnancy Proteins May Be MS Therapeutic Target

Proteins called PSGs suppress the pro-inflammatory activity of immune Th17 cells during pregnancy, potentially playing a protective role against complications and miscarriage, a study finds.  The impaired regulation of Th17 is associated with pregnancy complications, like preeclampsia and preterm delivery — and also with the development of autoimmune diseases such as multiple sclerosis (MS). According to the scientists, the results of this research could be used to develop new therapies not only for pregnancy maintenance…

You must be logged in to read/download the full post.